Selective loss of lymphoid component simulating myeloma in lymphoplasmacytic lymphoma treated with rituximab

Saved in:

Bibliographic Details
Published in:	British journal of haematology Vol. 161; no. 4; p. 460
Main Authors:	O'Connor, Simon R., Rana, Shabeeha K.
Format:	Journal Article
Language:	English
Published:	Oxford Blackwell 01-05-2013
Subjects:	Antibodies, Monoclonal, Murine-Derived - therapeutic use Antigens, CD20 - metabolism Antineoplastic Agents - therapeutic use Biological and medical sciences Hematologic and hematopoietic diseases Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Middle Aged Multiple Myeloma - metabolism Rituximab Tumors Waldenstrom Macroglobulinemia - drug therapy Waldenstrom Macroglobulinemia - metabolism Waldenstrom Macroglobulinemia - pathology Antineoplastic agent Immunopathology Hematology Rituximab B cell neoplasm Malignant hemopathy Immunocytoma Monoclonal antibody Lymphoid neoplasm Myeloma Cancerology Treatment Immunoglobulinopathy Lymphoproliferative syndrome Immunotherapy Cancer
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3
ISSN:	0007-1048 1365-2141
DOI:	10.1111/bjh.12307